Viewing Study NCT06630273



Ignite Creation Date: 2024-10-26 @ 3:42 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06630273
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-10-03

Brief Title: Canadian Initiative to Measure Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics
Sponsor: None
Organization: None

Study Overview

Official Title: Canadian Initiative to Measure Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CAN-IMPACT-IO
Brief Summary: The researchers doing this study are interested in doing the following

Biomarker research using fresh tumour tissue and normal blood cells and if required tumour tissue already collected
Bio-banking for use in future research using the collected tumour tissue blood
Detailed Description: This study is being done to enable the collection and study of these samples The results will also look at information on how participants with this type of cancer who received immunotherapy responded to treatment

Bio-banking is the collection storage and use of human body samples and related health information for future research It provides an important resource for health research locally across Canada and around the world The researchers doing the main study also are interested in storing any left-over tissue andor blood samples that have not been used up for future research The research that may be done on these samples in the future is unknown at this time

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None